Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongping Zhang

Showing results (261-270 of 264) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 264 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2022
Efficacy and Safety of the Anti-PD-L1 mAb Socazolimab for Recurrent or Metastatic Cervical Cancer: a Phase I Dose-Escalation and Expansion StudyJusheng An, Jie Tang, Benjamin X Li, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 4, 2025
Clinical characteristics of vulvar basal cell carcinoma: a multi-center, retrospective study in ChinaTingting Yao, Yuqin Huang, Qin Xu, et al.
BMC Genomics|March 6, 2022
Genome-wide recombination map construction from single sperm sequencing in cattleLiu Yang, Yahui Gao, Mingxun Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 25, 2025
Camrelizumab Plus Famitinib versus Camrelizumab Alone and Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer: A Randomized, Phase II StudyLingfang Xia, Keqiang Zhang, Ying Tang, et al.
Pageof 27

Showing results (261-270 of 264) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 264 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2022
Efficacy and Safety of the Anti-PD-L1 mAb Socazolimab for Recurrent or Metastatic Cervical Cancer: a Phase I Dose-Escalation and Expansion StudyJusheng An, Jie Tang, Benjamin X Li, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 4, 2025
Clinical characteristics of vulvar basal cell carcinoma: a multi-center, retrospective study in ChinaTingting Yao, Yuqin Huang, Qin Xu, et al.
BMC Genomics|March 6, 2022
Genome-wide recombination map construction from single sperm sequencing in cattleLiu Yang, Yahui Gao, Mingxun Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 25, 2025
Camrelizumab Plus Famitinib versus Camrelizumab Alone and Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer: A Randomized, Phase II StudyLingfang Xia, Keqiang Zhang, Ying Tang, et al.
Pageof 27